Cencora buys EyeSouth Partners retina unit for $1.1 billion
Cencora announced Monday it will buy EyeSouth Partners' retina business for $1.1 billion. The deal aims to expand the distributor's eye care unit operations.
Cencora, Inc., a prominent drug distributor, announced on Monday that it has reached an agreement to acquire the retina business of EyeSouth Partners for $1.1 billion. The acquisition is part of a broader strategy to expand the company's specialized eye care unit and enhance its service offerings within the ophthalmology sector.
The deal marks a significant investment in the specialty care market, as Cencora, Inc. looks to strengthen its presence in high-growth medical segments. EyeSouth Partners, an eye care network, provides a range of clinical and surgical services, and the divestiture of its retina business allows for a more focused expansion by the purchasing entity.
This transaction reflects the ongoing consolidation within the healthcare services industry, where large-scale distributors are increasingly integrating specialized clinical practices to provide more comprehensive support to healthcare providers and patients alike.
